| укр | рус |



No1-2(5) 2022

Back to the issue

DOI 10.37219/2528-8253-2022-1-78

Huijghebaert Suzy, Hoste Levi, Vanham Guido
Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19
Suzy Huijghebaert
Independent Research Support, La Hulpe, Belgium;;

Levi Hoste
Pediatric Pulmonology, Infectious Diseases and Immunology, Ghent University Hospital, Ghent, Belgium
Primary Immunodeficiency Research Lab, Center for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium

Guido Vanham
Department of Biomedical Sciences, Institute of Tropical Medicine and University of Antwerp, Antwerp, Belgium


Purpose: Nasal irrigation or nebulizing aerosol of isotonic or hypertonic saline is a traditional method for respiratory or nasal care. A recent small study in outpatients with COVID-19 without acute respiratory distress syndrome suggests substantial symptom resolution. We therefore analyzed pharmacological/pharmacodynamic effects of isotonic or hypertonic saline, relevant to SARS- CoV-2 infection and respiratory care.
Methods: Mixed search method.
Results: Due to its wetting properties, saline achieves an improved spreading of alveolar lining fluid and has been shown to reduce bio-aerosols and viral load. Saline provides moisture to respiratory epithelia and gels mucus, promotes ciliary beating, and improves mucociliary clearance. Coronaviruses and SARS-CoV-2 damage ciliated epithelium in the nose and airways. Saline inhibits SARS- CoV-2 replication in Vero cells; possible interactions involve the viral ACE2-entry
mechanism (chloride-dependent ACE2 configuration), furin and 3CLpro (inhibition by NaCl), and the sodium channel ENaC. Saline shifts myeloperoxidase activity in epithelial or phagocytic cells to produce hypochlorous acid. Clinically, nasal or respiratory airway care with saline reduces symptoms of seasonal coronaviruses and other common cold viruses. Its use as aerosol reduces hospitalization rates for bronchiolitis in children. Preliminary data suggest symptom reduction in symptomatic COVID-19 patients if saline is initiated within 48 h of symptom onset.
Conclusions: Saline interacts at various levels relevant to nasal or respiratory hygiene (nasal irrigation, gargling or aerosol). If used from the onset of common cold symptoms, it may represent a useful add-on to first-line interventions for COVID-19. Formal evaluation in mild COVID-19 is desirable as to establish efficacy and optimal treatment regimens.


Saline, Sodium chlorideЮ SARS-CoV-2, COVID-19, Mucociliary clearance, Acute respiratory distress syndrome.


  1. HNO-Ärzte im Netz (2020) Herausgegeben vom Deutschen Berufsverband der Hals-Nasen-Ohrenärzte e.V.) Tipps zur richtigen Nasenpflege [Tipps for adequate nasal care]. Accessed 19 June 2020
  2. Lungenartze im Netz (Lung doctors in the Net) (2020) Einfaches Inhalieren kann Tröpfcheninfektion effektiv eindämmern. [Simple inhalation can limit efficiently droplet infection] https://www.lungenaerzte-im-netz. de/news-archiv/meldung/article/einfaches-inhalierenkann-troepfcheninfektion-effektiv-eindaemmern/. Accessed 19 June 2020
  3. Praxisvita (das Portal für Gesundheit & Medizin) (2020) Inhalieren bei Corona: Wie wirksam ist das Hausmittel? [Inhalation during Corona; How effective is this home remedy?] https://www.praxisvita. de/coronavirus-dieses-hausmittel-hilft-bei-leichten-symptomen-18411.html. Accessed 19 June 2020
  4. Leichter Atmen bei Lungen- und bronchialerkrankungen (2020) Corona: Pflege der Atemwege vermindert Infektionsrisiko [Corona: Care of the airways reduces the risk of infection]. [24.03.2020] Accessed 19 June 2020
  5. PARI-Blog (2020) Treatment and nebuliser therapy for COVID- 19 in hospital. Interview with the Prof. Dr Kamin, Medical Director of the Hamm Lutheran Hospital. int/blog/treatment-and-nebuliser-therapy-for-covid-19-in-hospital-interview-with-the-prof-dr-kamin-medical-director-of- the-hamm-lutheran-hospital/. Accessed in English 27 July 2020. - Firstly accessed in German: Accessed 19 June 2020
  6. (2020) Coronavirus: Was Senioren & ihre Betreuer wissen müssen. [Coronavirus: What seniors and care givers need to know] Accessed 14 July 2020
  7. ETH Zurich (2020) Mit Atemwegspflege das Infektionsrisiko senken. [With airway care decrease the risk of infection.] veranstaltungen/eth-news/news/2020/03/zukunftsblog-viola-vogel-mit-atemwegspflege-das-infektionsrisiko-senken.html. Accessed 14 July 2020
  8. Bronchiectasis Toolbox (2020) Hydration and humidification. physiotherapy/principles-of-airway-clearance/ hydration-and-humidification. Accessed 13 July 2020
  9. Kramer A, Eggers M, Hübner N-O et al (2020) Empfehlung der DGKH. Viruzides Gurgeln und viruzider Nasenspray [Virucidal gargling and virucidal
    Nose sprays]. Deutsche Gesellschaft für Krankenhaushygiene e.V., 01.12.2020. Accessed 9 January 2021. pdfdata/2020_12_ 02_Empfehlung-viruzides-gurgeln-nasenspray.pdf
  10. Sciensano (2020) Consensus over het rationeel en correct gebruik van mondmaskers tijdens de COVID-19-pandemie [Consensus on the rational and correct use of mouth masks during the COVID-19 pandemic]. RMG_NL.pdf. Accessed 13 July 2020
  11. Sciensano (2020) Procedure voor huisartsen in geval van een mogelijk geval van COVID-19. Versie 08 juli 2020. [Procedure for doctors in the event of a possible case of COVID-19]. https:// procedure_GP_NL.pdf . Accessed 13 July 2020
  12. APB (2020) Aerosoltoestellen [Aerosol devices]. Information Up date 20 March 2020 . 2 0 Documents/NL/All%20partners/CORONAVIRUS_ AEROSOL_VERHUUR_20_03_20.pdf. Accessed 19 June 2020
  13. World Health Organization (2020) Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. Scientific Brief, 29 March 2020. publicationsdetail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. Accessed June 19, 2020.
  14. Pfeifer M, Ewig S, Voshaar T et al (2020) Position paper for the state-of-the-art application of respiratory support in patients with COVID-19. Respiration 99:521–541. 000509104
  15. Kimura KS, Freeman MH, Wessinger BC et al (2020) Interim analysis of an open-label randomized controlled trial evaluating nasal irrigations in non-
    hospitalized patients with COVID-19. Int Forum Allergy Rhinol Sep 11 [Epub ahead of print].
  16. Identifier: NCT04347538. Impact of nasal sa- line irrigations on viral load in patients with COVID-19. https:// show/record/NCT04347538?term= saline&cond=covid-19&draw=2&rank=1
  17. Santos FKG, Barros Neto EL, Moura TMCPA et al (2009) Molecular behavior of ionic and nonionic surfactants in saline medium. Colloids and Surfaces A: Physicochemical and Engineering Aspects 333:156–162. colsurfa.2008.09.040
  18. Staszak K, WieczorekD MK (2015) Effect of sodium chloride on the surface and wetting properties of  aqueous solutions of cocamidopropyl betaine. J Surfact Deterg 18:321–328. https://
  19. Avery ME, Mead J (1959) Surface properties in relation to atelec- tasis and hyaline membrane disease. AMA J Di Child 97(5_Part_I):517-5523. 02070010519001
  20. Ghadiali SN, Gaver DP (2008) Biomechanics of liquid-epithelium interactions in pulmonary airways. Respir Physiol Neurobiol 163(1-3):232-243.
  21. Huang J, Hume AJ, Abo KM et al (2020) SARS-CoV-2 infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response. bioRxiv [Preprint]: 175695.
  22. Takano H (2020) Pulmonary surfactant itself must be a strong defender against SARS-CoV-2. Medical Hypotheses 144: 110020.
  23. Edwards DA, Man JC, Brand P et al (2004) Inhaling to mitigate exhaled bioaerosols. Proc Natl Acad Sci USA 101(50):17383-17388.
  24. Edwards DA, Fiegel J, DeHaan W et al (2006) Novel inhalants for control and protection against airborne infections. Resp Drug Delivery 1:41-48
  25. Edwards D, Hickey A, Batycky R et al (2020) A new natural defense against airborne pathogens. QRB Discovery 1:e5.
  26. Fiegel J, Clarke R, Edwards DA (2006) Airborne infectious disease and the suppression of pulmonary bioaerosols. Drug Discov Today 11(1-2):51–57.
  27. Simonds A, Hanak A, Chatwin M et al (2010) Evaluation of droplet dispersion during non-invasive ventilation, oxygen thera- py, nebuliser treatment and chest physiotherapy in clinical prac- tice: implications for management of pandemic influenza and other airborne infections. Health Technol Assess 14:131–172. https://
  28. Hendley JO, Gwaltney JM (2004) Viral titers in nasal lining fluid compared to viral titers in nasal washes during experimental rhinovirus infection. J Clin Virol 30(4):326–328.
  29. Ramalingam S, Graham C, Dove J et al (2019) A pilot, open labelled randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep 9:1015.
  30. Watanabe W, Thomas M, Clarke R et al (2007) Why inhaling salt water changes what we exhale. J Colloid Interface Sci 307:71–78.
  31. Patel A, Longmore N, Mohanan A, Ghosh S (2019) Salt and pH- induced attractive interactions on the rheology of food protein- stabilized nanoemulsions. CS Omega 4(7):11791–11800. https://
  32. Wang Q, Li W, Hu N et al (2017) Ion concentration effect (Na+ and Cl-) on lipid vesicle formation. Colloids Surf B Biointerfaces. 155:287–293.
  33. Liu S, Novoselac A (2014) Transport of airborne particles from an unobstructed cough jet. Aerosol Sci Technol 48(11):1183–1194.
  34. Heyder J (2004) Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respi- ratory drug delivery. Proc Am Thorac Soc 1:315–320. https://doi. org/10.1513/pats.200409-046TA
  35. Rengasamy S, Zhuang Z, Niezgoda G et al (2018) A comparison of total inward leakage measured using sodium chloride (NaCl) and corn oil aerosol methods for air-purifying respirators. J Occup Environ Hyg 15(8):616–627.
  36. Negm N (2008) Solubilization characteristics of paraffin oil in different types of surfactants. Egyptian J Chem 51(1):21–29 publication/280015681_ Solubiliza-tion_characteristics_of_paraffin_oil_in_different_types_of_surfactants
  37. Baimes C (2020) Alberta researcher wins award for salt-coated mask innovation. The Canadian Press, CBC. alberta-researcher-award-salt-masks-covid-1.5813921. Accessed 10 January 2021
  38. Vejerano EP, Marr LC (2018) Physicochemical characteristics of evaporating respiratory fluid droplets. J R Soc Interface 15: 20170939.
  39.  Yang W, Elankumaran S, Marr LC (2012) Relationship between humidity and Influenza A viability in droplets and implications for influenza’s easonality. PLoS ONE 7(10):e46789.
  40. Wolf G, Koidl B, Pelzmann B (1991) [Zur Regeneration des Zilienschlages humaner Flimmerzellen] Regeneration of the ciliary beat of human ciliated ells. Laryngorhinootologie 70(10): 552–555.
  41. Daviskas E, Anderson SD, Gonda I et al (1996) Inhalation of hypertonic saline aerosol enhances mucociliary clearance in asthmatic and healthy subjects. Eur Respir J 9(4):725–732.
  42. Fu Y, Tong J, Meng F et al (2018) Ciliostasis of airway epithelial cells facilitates Influenza A virus infection. Vet Res 49(1):65.
  43. Keojampa BK, Nguyen MH, Ryan MW (2004) Effects of buff- ered saline solution on nasal mucociliary clearance and nasal air- way patency. Otolaryngol Head Neck Surg 131(5):679–682.
  44. Sood N, Bennett WD, Zeman K et al (2003) Increasing concentration of inhaled saline with or without amiloride: effect on mucociliary clearance in normal subjects. Am J Respir Crit Care Med 167(2):158–163. 293OC
  45. Kim C-H, Song MH, Ahn YE et al (2005) Effect of hypo-, iso- and hypertonic saline irrigation on secretory mucins and morphology of cultured human nasal epithelial cells. Acta Oto-Laryngologica 125:1296–1300.
  46. Sumaily I, Alarifi I, Alsuwaidan R et al (2020) Impact of nasal irrigation with iodized table salt solution on mucociliary clearance: proof-of-concept randomized control trial. Am J Rhinol Allergy 34(2):276–279.
  47. Min YG, Lee KS, Yun JB et al (2001) Hypertonic saline decreases ciliary movement in human nasal epithelium in vitro. Otolaryngol Head Neck Surg 124(3):313–316. 2001. 113145
  48. Bencova A, Vidan J, Rozborilova E, Kocan I (2012) The impact of hypertonic saline inhalation on mucociliary clearance and nasal nitric oxide. J Physiol Pharmacol 63(3):309–313 http://www.jpp.
  49. Talbot AR, Herr TM, Parsons DS (1997) Mucociliary clearance and buffered hypertonic saline solution. Laryngoscope 107(4): 500–503. 1097/00005537-199704000-00013
  50. Bennett WD, Wu J, Fuller F et al (2015) Duration of action of hypertonic saline on mucociliary clearance in the normal lung. J Appl Physiol 118(12):1483–1490. japplphysiol.00404.2014
  51. Middleton PG, Pollard KA, Wheatley JR (2001) Hypertonic saline alters ion transport across the human airway epithelium. Eur Resp J 17:195–199
  52. Jiao J, Yang J, Li J et al (2020) Hypertonic saline and seawater solutions damage sinonasal epithelial cell airliquid interface cul- tures. Int Forum Allergy Rhinol 10(1):59–68. 1002/alr.22459
  53. Miwa M, Matsunaga M, Nakajima N et al (2007) Hypertonic saline alters electrical barrier of the airway epithelium. Otolaryngol Head Neck Surg 136(1):62–66. 1016/j.otohns.2006.08.013
  54. Hauptman G, Ryan MW (2007) The effect of saline solutions on nasal patency and mucociliary clearance in rhinosinusitis patients. Otolaryngol Head Neck Surg 137(5):815–821. 1016/j.otohns2007.07.034
  55. Balmes JR, Fine JM, Christian D et al (1988) Acidity potentiates bronchoconstriction induced by hypoosmolar aerosols. Am Rev Respir Dis 138(1):35–39.
  56. Makker HK, Holgate ST (1993) The contribution of neurogenic reflexes to hypertonic saline-induced bronchoconstriction in asthma. J Allergy Clin Immunol 92:82–88.
  57. Taube C, Holz O, Mücke M et al (2001) Airway response to inhaled hypertonic saline in patients with moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1810–1815. 2104024
  58. Lowry RH, Wood AM, Higenbottam TW (1988) Effects of pH and osmolarity on aerosol-induced cough in normal volunteers. Clin Sci (Lond) 74(4):373–376.
  59. Mandelberg A, Amirav I (2010) Hypertonic saline or high volume normal saline for viral bronchiolitis: mechanisms and rationale. Paed Pulmonol 45:36–40.
  60. Bartoszewski R, Matalon S, Collawn JF (2017) Ion channels of the lung and their role in disease pathogenesis. Am J Physiol Lung Cell Mol Physiol
  61. Fahy JV, Dickey BF (2010) Airway mucus function and dysfunc- tion. N Engl J Med 2363(23):2233–2247. NEJMra0910061
  62. Bustamante-Marin XM, Ostrowski LE (2017) Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol 9(4): a028241. cshperspect.a028241
  63.  Hollenhorst MI, Richter K, Fronius M (2011) Ion transport by pulmonary epithelia. J Biomed Biotechnol Article ID 174306, 16pages.
  64. Iwan IH, Dziembowska I, Słonina DA (2019) Airways surface liquid and ion Transport - The mechanism maintained patency. Biom J Scie Techn Res 14(3):1-7.
  65. Pinto JM, Jeswani S (2010) Rhinitis in the geriatric population. Allergy Asthma Clin Immunol 6(1):10. 1710-1492-6-10
  66. Lillehoj EP, Kato K, Lu W, Kim KC (2013) Cellular and molec- ular biology of airway mucins. Int Rev Cell Mol Biol 303:139–202.
  67. Lieleg O, Vladescu I, Ribbeck K (2010) Characterization of par- ticle translocation through mucin hydrogels. Biophys J 98:1782–1789.
  68. McCullagh CM, Jamieson AM, Blackwell J, Gupta R (1995) Viscoelastic properties of human tracheobronchial mucin in aqueous solution. Biopolymers
  69. Button B, Goodell HP, Atieh E et al (2018) Roles of  mucus adhe- sion and cohesion in cough clearance. PNAS 115(49):12501–12506.
  70. Wills PJ, Hall RL, Wm C, Cole PJ (1997) Sodium chloride in- creases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucusdepleted bovine trachea. J Clin Inv 99(1):9–13
  71. Lin L, Chen Z, Cao Y, Sun G (2017) Normal saline solution nasal- pharyngeal irrigation improves chronic cough associated with allergic rhinitis. Am J Rhinol Allergy 31(2):96–104. 2017.31.4418
  72. Elkins MR, Bye PT (2011) Mechanisms and applications of hy- pertonic saline. J R Soc Med 104(Suppl 1):S2–S5.
  73. Goralski JL, Wu D, Thelin WR et al (2018) The in vitro effect of nebulised hypertonic saline on human bronchial epithelium. Eur Respir J 51(5):1702652. 02652-2017
  74. Boon M, Jorissen M, Jaspers M et al (2016) The influence of nebulized drugs on nasal ciliary activity. J Aerosol Med Pulm Drug Deliv 29(4):378–385. 1229
  75. Rusznak C, Devalia JL, Lozewicz S, Davies RJ (1994) The assessment of nasal mucociliary clearance and the effect of drugs. Respir Med 88(2):89-101.
  76. Workman AD, Cohen NA (2014) The effect of drugs and other compounds on the ciliary beat frequency of  human respiratory epithelium. Am J Rhinol Allergy 28(6):454-464.
  77. Rivera JA (1962) Cilia, ciliated epithelium, and ciliary activity. International Series of Monographs and Applied Biology. 1st edn. Pergamon Press ltd, Oxfor-London-NewYork-Paris pp.50-58. ISBN 978008009623
  78. Paul P, Johnson P, Ramaswamy P et al (2013) The effect of ageing on nasal mucociliary clearance in women: a pilot study. Pulmonol Article ID598589:5 pages.
  79. Purushothaman PK, Priyangha E, Vaidhyswaran R (2020) Effects of prolonged use of facemask on healthcare workers in tertiary care hospital during COVID-19 pandemic. Indian J Otolaryngol Head Neck Surg:1–7. 0
  80. White DE, Bartley J, Nates RJ (2015) Model demonstrates func- tional purpose of the nasal cycle. BioMed Eng OnLine 14:38. 10.1186/s12938-015-0034-4
  81. Tarran R, Trout L, Donaldson SH, Boucher RC (2006) Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia. J Gen Physiol 127(5):591–604.
  82. Hildenbrand T, Weber RK, Brehmer D (2011) Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature. Eur Arch Otorhinolaryngol 268(1):17–26. 010-1391-z
  83. Harvey PR, Tarran R, Garoff S, Myerburg MM (2011) Measurement of the airway surface liquid volume with simple light refraction microscopy. Am J Respir Cell Mol Biol 45(3): 592–599.
  84. Tanner K, Roy N, Merrill RM et al (2010) Nebulized isotonic saline versus water following a laryngeal desiccation challenge in classically trained sopranos. J Speech Language Hearing Res 53(6):1555–1566.
  85. Personal communications by pneumologists, dentists and paedia- tricians wearing daily well-fitting professional masks, July- October 2020
  86. Slapak I, Skoupa J, Strnad P, Hornik P (2008) Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 134:67–74. https://
  87. Newster (2020) Eco-sustainable technology for the processing of healthcare waste (HCW), on-site or in centralized treatment centers. Coronaviruses: SARS, MERS and Covid19. 28/02/2020 http://
  88. Machado RRG, Glaser T, Araujo DB et al (2020) Hypertonic saline solution inhibits SARS-CoV-2 in vitro assay. bioRxiv 2020.08.04:235549.
  89. Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS- CoV-2 Cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2): 271–280.e8.
  90. Hou Y, Zhao J, Martin W et al (2020) New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. BMC Med 18:art.No.216.
  91. Sungnak W, Huang N, Bécavin C et al (2020) SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat Med 26:681–687. 1038/s41591-020-0868-6
  92. Rushworth CA, Guy JL, Turner AJ (2008) Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis. FEBS J 275(23):6033–6042. https://doi. org/10.1111/j.1742-4658.2008.06733
  93.  Guy JL, Jackson RM, Acharya KR et al (2003) Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 42(45):13185–13192.
  94. Vincent MJ, Bergeron E, Benjannet S et al (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69.
  95. Chitranshi N, Gupta VK, Rajput R et al (2020) Evolving geo- graphic diversity in SARS-CoV2 and in silico analysis of replicat- ing enzyme 3CLpro targeting repurposed drug candidates. J Transl Med 18(1):278. 02448-z
  96. Graziano V, McGrath WJ, DeGruccio AM et al (2006) Enzymatic activity of the SARS coronavirus main proteinase dimer. FEBS letters 580(11):2577–2583. 04.004
  97. Ferreira JC, Rabeh WM (2020) Biochemical and Biophysical characterization of the main protease, 3-chymotrypsin-like prote- ase (3CLpro), from the novel coronavirus disease 19(COVID-19). Research Square. New York University Abu Dhabi, pp 1-17. e41c3648-96c7-4953-bb2b-a5c5d1a19e7f.pdf
  98. Chang HP, Chou CY, Chang GG (2007) Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride. Biophys J 92(4):1374–1383. https://doi. org/10.1529/ biophysj.106.091736
  99. Abian O, Ortega-Alarcon D, Jimenez-Alesanco A et al (2020) Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening. Int J Biol Macromol 164:1693–1703. 2020.07.235
  100. Grum-Tokars V, Ratia K, Begaye A et al (2008) Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery. Virus Res 133(1):63-73.
  101. Shi J, Song J (2006) The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. The FEBS Journal 273(5):1035–1045. https:// 05130.x
  102. Bestle D, Heindl MR, Limburg H et al (2020) TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells.
    Life Sci Alliance 3(9):e202000786. https://
  103. Shang J, Wan Y, Luo C et al (2020) Cell entry mechanisms of SARS-CoV-2. PNAS 117(21):11727–11734.
  104. Hasan A, Paray BA, Hussain A et al (2020) A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. J Biomol Struct Dyn:1-9. https:// 07391102.2020.1754293
  105. Izidoro MA, Gouvea IE, Santos JA et al (2009) Lindberg I, Juliano L (2009) A study of human furin specificity using synthetic pep- tides derived from natural substrates, and effects of potassium ions. Arch Biochem Biophys 487(2):105–114.
  106. Zhou T, Tsybovsky Y, Olia AS et al (2020) A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike. bioRxiv [Preprint]
    2020.07.04.187989 2020.07. 04.187989
  107. Ou X, Liu Y, Lei X et al (2020) Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross- reactivity with SARS-CoV. Nat Commun 11(1):1620. https://
  108. Smyrlaki I, Ekman M, Lentini A et al (2020) Massive and rapid COVID-19 testing is feasible by extractionfree SARS-CoV-2 RT-PCR. Nat Commun 11:4812.
  109. Fischer H, Widdicombe JH (2006) Mechanisms of acid and base secretion by the airway epithelium. J Membr Biol 211(3):139-150.
  110. Reddi BA (2013) Why is saline so acidic (and does it really mat- ter?). Int J Med Sci 10(6):747–750. 5868
  111. Enuka Y, Hanukoglu I, Edelheit O et al (2012) Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways. Histochem Cell Biol 137(3): 339–353.
  112.  Anand P, Puranik A, Aravamudan M et al (2020) SARS-CoV-2 strategically mimics proteolytic activation of human ENaC. eLife 9:e58603.
  113.  Jaimes JA, Millet JK, Whittaker GR (2020) Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site. iScience 23:101212. 101212
  114. Ji HL, Zhao R, Matalon S, Matthay MA (2020) Elevated plas- min(ogen) as a common risk factor for COVID-19 susceptibility. Physiol Rev 100(3):1065–1075. 00013.2020
  115. Kleyman TR, Carattino MD, Hughey RP (2009) ENaC at the cutting edge: regulation of epithelial sodium channels by prote- ases. J Biol Chem 284(31):20447–20451. jbc.R800083200
  116. Szabó GT, Kiss A, Csanádi Z, Czuriga D (2020) Hypothetical dysfunction of the epithelial sodium channel may justify neurohumoral blockade in coronavirus disease 2019. ESC Heart Fail 17.
  117. Noda M, Hiyama TY (2015) The Nax Channel: What it is and what it does. The Neuroscientist 21(4):399–412. 10.1177/1073858414541009
  118. Marunaka Y, Marunaka R, Sun H et al (2016) Na+ homeostasis by epithelial Na+ channel (ENaC) and Nax channel (Nax): cooperation of ENaC and Nax. ATM 4(Suppl 1):S11. 21037/atm.2016.10.42
  119. Blé FX, Cannet C, Collingwood S et al (2010) ENaC-mediated effects assessed by MRI in a rat model of hypertonic saline-induced lung hydration. Br J Pharmacol 160(4):1008–1015. /j.1476-5381.2010.00747.x
  120. Ramalingam S, Cai B, Wong J et al (2018) Antiviral innate im- mune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels. Sci Rep 8: 13630.
  121. Zhang N, Francis KP, Prakash A, Ansaldi D (2013) Enhanced detection of myeloperoxidase activity in deep tissues through luminescent excitation of nearinfrared nanoparticles. Nat Med 19(4):500–505.
  122. Suzuki K, Yamada M, Akashi K, Fujikura T (1986) Similarity of kinetics of three types of myeloperoxidase from human leukocytes and four types from HL-60. Arch Biochem Biophysics 245(1): 167–173. 90201-8
  123. Wang G, Nauseef WM (2015) Salt, chloride, bleach, and innate host defense. J Leukocyte Biol 98(2):163–172. 1189/jlb.4RU0315-109R
  124. Chandler JD, Day BJ (2012) Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties. Biochem Pharmacol 84(11):1381-1387. j.bcp.2012. 07.029
  125. Nadesalingam A, Chen JHK, Farahvash A, Khan MA (2018) Hypertonic saline suppresses NADPH oxidasedependent neutrophil extracellular trap formation and promotes apoptosis. Front Immunol 9:359.
  126. Delgado-Enciso I, Paz-Garcia J, Barajas-Saucedo CE, Mokay- Ramírez KA Meza-Robles C, Lopez-Flores R (2020) Patient- reported health outcomes after treatment of COVID-19 with neb- ulized and/or intravenous neutral electrolyzed saline combined with usual medical care versus usual medical care alone: a randomized, open-label, controlled trial. Res Sq [Preprint]
  127. WHO (2020) Saline. emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters#saline
  128. WHO (2020) Can rinsing your nose regularly with saline solution prevent Covid-19? https://www.who. int/docs/default-source/searo/thailand/12myths- final099bfbf976c54d5fa3407a65b6d 9fa9d.pdf
  129. Salmon Ceron D, Bartier S, Hautefort C et al (2020) APHP COVID-19 research collaboration. Selfreported loss of smell without nasal obstruction to identify COVID-19. The multicenter Coranosmia cohort study. J Infect 81(4):614–620.
  130. Voshaar T. COVID-19 Therapie aus Sicht eines Aerosol-Experten. - Artzeportal 28 Juli 2020. covid-19-therapie-aus-sicht-eines-aerosol-experten Accessed 10 January 2021
  131. Jayaweera M, Perera H, Gunawardana B, Manatunge J (2020) Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ Res 188: 109819.
  132. WHO (2020) Transmission of SARS-CoV-2: implications for infection prevention precautions. commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions Accessed 10 Jan-uary 2021
  133. Ueki H, Furusawa Y, Iwatsuki-Horimoto K et al (2020) Effectiveness of face masks in preventing airborne transmission of SARS-CoV-2. mSphere 5(5):e00637–e00620. 10.1128/ mSphere.00637-20
  134. Ehre C (2020) SARS-CoV-2 infection of airway cells. N Engl J Med 383:969.
  135. Zhu N, Wang W, Liu Z et al (2020) Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat Commun 11:3910.
  136. Robinot R, Hubert M, Dias de Mehlo G et al (2020) SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance. bioRxiv.
  137. Baker AN, Richards SJ, Guy CS et al (2020) The SARS-COV-2 spike protein binds sialic acids and enables rapid detection in a lateral flow point of care diagnostic device. ACS Cent Sci 6(11): 2046–2052.
  138. Hou YJ, Okuda K, Edwards CE et al (2020) SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182(2):429–46.e14. 05.042
  139. Burke W (2014) The ionic composition of nasal fluid and its function. Health 06(08):720-728. 2014.68093 _2014032610554655.pdf
  140. Grandjean Lapierre S, Phelippeau M, Hakimi C et al (2017) Cystic fibrosis respiratory tract salt concentration: an exploratory cohort study. Medicine 96(47):e8423.
  141. Kozlova I, Vanthanouvong V, Johannesson M, Roomans GM (2006) Composition of airway surface liquid determined by X- ray microanalysis. Ups J Med Sci 111(1):137-153. https://doi. org/10.3109/2000-1967-016 pdf/10.3109/2000-1967-016
  142. Matsui H, Grubb BR, Tarran R et al (1998) Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95(7): 1005–1015.
  143. Wheatley CM, Cassuto NA, Foxx-Lupo WT et al (2010) Variability in measures of exhaled breath Na+, influence of pul- monary blood flow and salivary Na+.Clin Med Insights Circ Respir Pulm Med 4:25–34.
  144. Song Y, Thiagarajah J, Verkman AS (2003) Sodium and chloride concentrations, pH, and depth of airway surface liquid in distal airways. J Gen Physiol 122(5):511–519.
  145. Hao W, Ma B, Li Z et al (2020) Binding of the SARS-CoV-2 spike protein to glycans. bioRxiv. 05.17.100537
  146. Bastier PL, Lechot A, Bordenave L et al (2015) Nasal irrigation: from empiricism to evidence-based medicine. A review. Eur Ann Otorhinolaryngol Head Neck Dis 132(5):281–285.
  147. Nimsakul S, Ruxrungtham S, Chusakul S et al (2018) Does heating up saline for nasal irrigation improve mucociliary function in chronic rhinosinusitis? Am J Rhinol Allergy 32(2):106–111.
  148. Niedner R (1997) Cytotoxicity and sensitization of  povidone-iodine and other frequently used antiinfective agents. Dermatology 195(Suppl2):89-92.
  149. Gudmundsdottir Á, Scheving R, Lindberg F, Stefansson B (2020) Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme® a medical device mouth spray against the common cold. J Med Virol. 554.
  150. Kido H (2015) Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options. Proc Jpn Acad Ser B Phys Biol Sci 91(8):351–368.
  151. Liu JJ, Chan GC, Hecht AS et al (2014) Nasal saline irrigation has no effect on normal olfaction: a prospective randomized trial. Int Forum Allergy Rhinol
  152. Piromchai P, Puvatanond C, Kirtsreesakul V et al (2019) Effectiveness of nasal irrigation devices: a Thai multicentre survey. PeerJ 27(7):e7000.
  153. Navarra J, Ruiz-Ceamanos A, Moreno JJ et al (2002) Acute nasal dryness in COVID-19. medRxiv 2020.11.18.20233874 [Preprint].

© 2019, Public Organization «Ukrainian Scientific Medical Society of Otorhinolaryngologists»